Smart & Biggar announces Lynn Ing as new counsel
January 3, 2020
Smart & Biggar, Canada’s leading firm for intellectual property law, congratulates Lynn Ing on her promotion to counsel.
Lynn has more than a decade of experience in patent prosecution and litigation, bolstered by her strong scientific expertise and background in cancer research. Among her many accomplishments, Lynn held an integral role in the successful appeal to the Supreme Court of Canada in AstraZeneca v Apotex, 2017 SCC 36, leading to the abolishment of the “promise doctrine” of patent utility in Canada. Lynn advises clients on biotechnology, chemical and pharmaceutical patent applications including for biologics, and represents them in patent infringement, impeachment and damages actions and litigation under the Patented Medicines (Notice of Compliance) Regulations.
To learn more about Lynn, please visit Smart & Biggar’s website.
Smart & Biggar
www.smartbiggar.caSmart & Biggar is widely recognized as Canada’s leading intellectual property firm, with offices in Montréal, Ottawa, Toronto, Vancouver and Calgary. We are leaders in intellectual property and have been serving clients for over a century. Smart & Biggar operates as part of the IPH Limited group, under its own brand and independent from other IPH member firms.
Lynn Ing
Smart & Biggar
Law School
University of Toronto
Year Of Call
2003
Area Of Practice
Intellectual Property